1-9 of 9
pomalidomide
Close
Sort by
Journal Articles

Preclinical activity and determinants of response of the GPRC5DxCD3 bispecific antibody talquetamab in multiple myeloma

Christie P. M. Verkleij, Marloes E. C. Broekmans, Mark van Duin, Kristine A. Frerichs, Rowan Kuiper, A. Vera de Jonge, Martin Kaiser, Gareth Morgan, Amy Axel, Rengasamy Boominathan, Jocelyn Sendecki, Amy Wong, Raluca I. Verona, Pieter Sonneveld, Sonja Zweegman, Homer C. Adams, III, Tuna Mutis, Niels W. C. J. van de Donk
Journal: Blood Advances
Blood Adv (2021) 5 (8): 2196–2215.
https://doi.org/10.1182/bloodadvances.2020003805
Published: 2021
Includes: Supplemental data
Journal Articles

HRI depletion cooperates with pharmacologic inducers to elevate fetal hemoglobin and reduce sickle cell formation

Scott A. Peslak, Eugene Khandros, Peng Huang, Xianjiang Lan, Carly L. Geronimo, Jeremy D. Grevet, Osheiza Abdulmalik, Zhe Zhang, Belinda M. Giardine, Cheryl A. Keller, Junwei Shi, Ross C. Hardison, Gerd A. Blobel
Journal: Blood Advances
Blood Adv (2020) 4 (18): 4560–4572.
https://doi.org/10.1182/bloodadvances.2020002475
Published: 2020
Includes: Supplemental data
Journal Articles

Immunomodulatory drugs suppress Th1-inducing ability of dendritic cells but enhance Th2-mediated allergic responses

Vien Phan, Tomoki Ito, Muneo Inaba, Yoshiko Azuma, Kayoko Kibata, Noriko Inagaki-Katashiba, Akihiro Tanaka, Atsushi Satake, Shosaku Nomura
Journal: Blood Advances
Blood Adv (2020) 4 (15): 3572–3585.
https://doi.org/10.1182/bloodadvances.2019001410
Published: 2020
Includes: Supplemental data
Journal Articles

Impact of last lenalidomide dose, duration, and IMiD-free interval in patients with myeloma treated with pomalidomide/dexamethasone

Clinical Trials & Observations
Efstathios Kastritis, Maria Roussou, Maria Gavriatopoulou, Nikolaos Kanellias, Magdalini Migkou, Evangelos Eleutherakis-Papaiakovou, Dimitrios C. Ziogas, Despina Fotiou, Ioannis Ntanasis-Stathopoulos, Ioanna Dialoupi, Stavroula Giannouli, Panagiotis Tsirigotis, Sossana Delimpasi, Despina Mparmparousi, Mairylin Spyropoulou-Vlachou, Aikaterini Xirokosta, Evangelos Terpos, Meletios A. Dimopoulos
Journal: Blood Advances
Blood Adv (2019) 3 (23): 4095–4103.
https://doi.org/10.1182/bloodadvances.2019000539
Published: 2019
Journal Articles

Genome-wide CRISPR screens reveal genetic mediators of cereblon modulator toxicity in primary effusion lymphoma

Ajinkya Patil, Mark Manzano, Eva Gottwein
Journal: Blood Advances
Blood Adv (2019) 3 (14): 2105–2117.
https://doi.org/10.1182/bloodadvances.2019031732
Published: 2019
Includes: Supplemental data
Journal Articles

Phase 2 study of clarithromycin, pomalidomide, and dexamethasone in relapsed or refractory multiple myeloma

Clinical Trials & Observations
Tomer M. Mark, Peter A. Forsberg, Adriana C. Rossi, Roger N. Pearse, Karen A. Pekle, Arthur Perry, Angelique Boyer, Linda Tegnestam, David Jayabalan, Morton Coleman, Ruben Niesvizky
Journal: Blood Advances
Blood Adv (2019) 3 (4): 603–611.
https://doi.org/10.1182/bloodadvances.2018028027
Published: 2019
Includes: Supplemental data
Journal Articles

Changes in bone marrow innate lymphoid cell subsets in monoclonal gammopathy: target for IMiD therapy

Clinical Trials & Observations
Jithendra Kini Bailur, Sameet Mehta, Lin Zhang, Natalia Neparidze, Terri Parker, Noffar Bar, Tara Anderson, Mina L. Xu, Kavita M. Dhodapkar, Madhav V. Dhodapkar
Journal: Blood Advances
Blood Adv (2017) 1 (25): 2343–2347.
https://doi.org/10.1182/bloodadvances.2017012732
Published: 2017
Includes: Supplemental data
Journal Articles

A phase 2 study of panobinostat with lenalidomide and weekly dexamethasone in myeloma

Clinical Trials & Observations
Ajai Chari, Hearn J. Cho, Amishi Dhadwal, Gillian Morgan, Lisa La, Katarzyna Zarychta, Donna Catamero, Erika Florendo, Nadege Stevens, Daniel Verina, Elaine Chan, Violetta Leshchenko, Alessandro Laganà, Deepak Perumal, Anna Huo-Chang Mei, Kaity Tung, Jami Fukui, Sundar Jagannath, Samir Parekh
Journal: Blood Advances
Blood Adv (2017) 1 (19): 1575–1583.
https://doi.org/10.1182/bloodadvances.2017007427
Published: 2017
Includes: Supplemental data
Journal Articles

Recent trends in multiple myeloma incidence and survival by age, race, and ethnicity in the United States

Clinical Trials & Observations
Luciano J. Costa, Ilene K. Brill, James Omel, Kelly Godby, Shaji K. Kumar, Elizabeth E. Brown
Journal: Blood Advances
Blood Adv (2017) 1 (4): 282–287.
https://doi.org/10.1182/bloodadvances.2016002493
Published: 2017
Includes: Supplemental data